A 41-year-old Chinese woman was admitted to our hospital with epigastric pain. Computed tomography detected a heterogeneous enhancement tumor fed by the left gastroepiploic artery in the left lower quadrant and cholelithiasis. Excision of the tumor in the greater omentum and cholecystectomy were performed laparoscopically. Histological findings confirmed a diagnosis of hemangiopericytoma with low-grade malignancy. To our knowledge, hemangiopericytoma of the greater omentum is very rare, and only 12 cases were reported in English literature. We report a case of hemangiopericytoma arising in the greater omentum and review the literature.
A resectable case of liver metastasis from gastric cancer is rare and has a poor prognosis. We treated a patient with liver metastasis from early gastric cancer in a 65-year-old man who have a 5-year survival. The patient who had undergone a distal partial gastrectomy for early gastric cancer at another hospital 4 years earlier was found to have a metastatic tumor invaded the remnant stomach and pancreas body with high CA19-9 value (2,490U/ml). Left lateral segment of the liver, remnant stomach, distal pancreas and spleen were resected en block. Over 5 years passed since the operation, and no signs of recurrence have occurred with normal CA19-9 level. In our institute, the incidence of liver metastasis from early gastric cancer was 1.17% of a total of 426 cases operated on for early gastric cancer from 1980 to 1992. Although a recurrence case of gastric cancer with high CA19-9 is believed to have poor prognosis, a long-term survival might be expected, if surgery successfully normalizes the high CA19-9 level like in this case.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.